Advertisement

Targetable Nanoparticles

  • P. Couvreur
  • V. Lenaerts
  • A. Ibrahim
  • L. Grislain
  • L. Van Snick
  • P. Guiot
  • C. Verdun
  • F. Brasseur
Part of the NATO ASI Series book series (NSSA, volume 113)

Abstract

The concept of drug-carriers has been developed as an alternative to a tissue distribution dependant on the molecular action of the drug. Classically, an intravenously administered drug is distributed in the body as a function of intrinsic properties of the molecule. A pharmacologically active concentration is reached in the diseased tissue at the expense of massive distribution in the rest of the body. For many drugs, e.g. cytostatics or antileishmaniasis agents, this poor specificity raises a toxicological problem which represents a real obstacle to an effective therapy. An improvement to this situation could be brought about by the use of a carrier directing the drug to the target tissue.

Keywords

Anionic Polymerization Mouse Peritoneal Macrophage Frit Glass Filter Circulation Tube Colloidal Drug Delivery System 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    G. Gregoriadis, C.P. Swain, E.J. Wills and A.S. Tavill, Drug-carrier potential of liposomes in cancer chemotherapy, Lancet 1:1313 (1974).CrossRefGoogle Scholar
  2. 2.
    M.J. Kosloski, F. Rosen, R.J. Milholland and D. Papahadjopoulos, Effect of lipid vesicle (liposome) encapsulation of methotrexate on its chemotherapeutic efficacy in solid rodent tumors, Cancer Res. 38:2848 (1978).Google Scholar
  3. 3.
    J. Kreuter and P. Speiser, In-vitro studies of poly (methylmetacrylate) adjuvants, J. Pharm. Sci. 65:1624 (1976).CrossRefGoogle Scholar
  4. 4.
    P. Couvreur, P. Tulkens, M. Roland, A. Trouet and P. Speiser, Nano-capsules a new type of lysosomotropic carrier, Febs Lett. 84:323 (1977).CrossRefGoogle Scholar
  5. 5.
    P. Couvreur, B. Kante, M. Roland, P. Guiot, P. Baudhuin and P. Speiser, Polycyanoacrylate nanocapsules as potential lysosomotropic carriers: preparation, morphological and sorptive properties, J. Pharm. Pharmacol. 31:331 (1979).CrossRefGoogle Scholar
  6. 6.
    P. Couvreur, M. Roland and P. Speiser, Biodegradable submicroscopic particles containing a biologically active substance and compositions containing them, US Patent, 4 329 332 (1982).Google Scholar
  7. 7.
    W.R. Vezin and A.T. Florence, In-vitro heterogenous degradation of poly (n-alkylcyanoacrylates), J. Biomed. Mater. Res. 14:93 (1980).CrossRefGoogle Scholar
  8. 8.
    F. Leonard, R. Kulkarni, G. Brandes, J. Nelson and J. Cameron, Synthesis and degradation of poly (alkyl-fcyanoacrylates), J. Appl. Polym. Sci. 10:259 (1966).CrossRefGoogle Scholar
  9. 9.
    F. Leonard, R. Kulkarni, J. Nelson and G. Brandes, Tissue-adhesives and hemostasis-inducing compounds: the alkylcyanoacrylates, J. Biomed. Mater. Res. 1:3 (1967).CrossRefGoogle Scholar
  10. 10.
    L. van Snick, P. Couvreur, D. Christiaens-Leyh and M. Roland, Molecular weights of free and drug-loaded nanoparticles, Pharm. Res. 1:36 (1985).Google Scholar
  11. 11.
    C. Verdun, P. Couvreur, H. Vranckx, V. Lenaerts and M. Roland, Development of a nanoparticle controlled release formulation for human use, submitted (1985).Google Scholar
  12. 12.
    A. Ibrahim, P. Gouvreur, M. Roland and P. Speiser, New magnetic drug carrier, J. Pharm. Pharmacol. 35:59 (1983).CrossRefGoogle Scholar
  13. 13.
    P. Guiot and P. Couvreur, Quantitative study of the interaction between polybutylcyanoacrylate nanoparticles and mouse peritoneal macrophages in culture, J. Pharm. Belg. 38:130 (1983).Google Scholar
  14. 14.
    L. Grislain, P. Couvreur, V. Lenaerts, M. Roland, D. Deprez-Decampeneere and P. Speiser, Pharmacokinetics and distribution of a biodegradable drug-carrier, Int. J. Pharm. 15:334 (1983).CrossRefGoogle Scholar
  15. 15.
    V. Lenaerts, J.F. Nagelkerke, T.J.C. van Berkel, P. Couvreur, L. Grislain, M. Roland and P. Speiser, In-vivo uptake of polyiso-butylcyanoacrylate nano-particles by rat liver Kupffer, Endothelial and Parenchymal Cells, J. Pharm. Sci. 73:980 (1984).CrossRefGoogle Scholar
  16. 16.
    J.F. Nagelkerke, K.P. Barto and T.J.C. van Berkel, in: “Sinusoidal Liver Cells”, D.L. Knook and E. Wisse, eds., Elsevier North-Holland Biomedical Press, Amsterdam (1983).Google Scholar
  17. 17.
    O.H. Lowry, N.J. Rosebrough, A.L. Farr and M.J. Randall, Protein measurement with folin-phenol reagent, J. Biol. Chem. 193:265 (1951).Google Scholar
  18. 18.
    B. Kante, P. Couvreur, V. Lenaerts, P. Guiot, M. Roland, P. Baudhuin and P. Speiser, Tissue distribution of 3H-actinomycin D adsorbed on polybutylcyanoacrylate nanoparticles, Int. J. Pharm. 7:45 (1980).CrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1986

Authors and Affiliations

  • P. Couvreur
    • 1
  • V. Lenaerts
    • 2
  • A. Ibrahim
    • 2
  • L. Grislain
    • 2
  • L. Van Snick
    • 2
  • P. Guiot
    • 2
  • C. Verdun
    • 2
  • F. Brasseur
    • 2
  1. 1.Laboratoire de Pharmacie GaléniqueUniversité de Paris XIChatenay-MalabryFrance
  2. 2.Laboratoire de Pharmacie GaléniqueUniversité Catholique de LouvainBrusselsBelgium

Personalised recommendations